High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy.

Research output: Contribution to journalArticle

Abstract

To assess the prognostic importance of high-sensitive C reactive protein (hsCRP) in patients with mild to moderate aortic valve stenosis during placebo or simvastatin/ezetimibe treatment in Simvastatin and Ezetimibe in Aortic Stenosis (SEAS).

Details

Authors
  • Adam Blyme
  • Camilla Asferg
  • Olav W Nielsen
  • Thomas Sehestedt
  • Y Antero Kesäniemi
  • Christa Gohlke-Bärwolf
  • Kurt Boman
  • Ronnie Willenheimer
  • Simon Ray
  • Christoph A Nienaber
  • Anne Rossebø
  • Kristian Wachtell
  • Michael H Olsen
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cardiac and Cardiovascular Systems
Original languageEnglish
Pages (from-to)e000152
JournalOpen Heart
Volume2
Issue number1
Publication statusPublished - 2015
Publication categoryResearch
Peer-reviewedYes

Total downloads

No data available